Indication
Topical treatment of clinically typical, nonhyperkeratotic, nonhypertrophic, visible or palpable actinic keratosis (AK) of the full face or balding scalp in immunocompetent adults when other topical treatment options are contraindicated or less appropriate.

Medicine details

Medicine name:
imiquimod (Zyclara)
SMC ID:
SMC2211
Pharmaceutical company
Meda Pharmaceuticals Ltd
BNF chapter
Skin
Submission type
Full
Status
Publication due date:
11 November 2019
SMC meeting date:
01 October 2019
Patient group submission deadline:
02 September 2019